IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences: Event: Wells Fargo Healthcare Conference Date: Thursday, September 8, 2022 Time: 10:25 a.m. Eastern Time … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Vietnam Pharmacy Retail Market, By Market Structure (Organized v/s Unorganized), By Product Type, By Therapeutic Area, By Drug Type, By Pharmacy Location, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. Vietnam pharmacy retail market is projected to grow at a significant rate during the forecast period. The … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Continuous Renal Replacement Therapy (CRRT) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026 Amid the COVID-19 crisis, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.4 Billion in the year 2022, is … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Gene Therapy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Gene Therapy Market to Reach $2.7 Billion by 2026 Amid the COVID-19 crisis, the global market for Gene Therapy estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2.7 Billion … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic eCommerce Business Models Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This study assesses the eCommerce business potential across sectors, creating resilient healthcare and diagnostic market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable, cost-efficient business opportunities with new B2B products, customized outsourcing services, and … [Read more…]
With this recommendation, eligible patients in England, Wales and Northern Ireland will be able to access the first orally administered therapy for GPA/MPA, two main forms of ANCA-associated vasculitis (AAV) Launch of Tavneos® in the UK is expected in the next weeks ST. GALLEN, Switzerland–(BUSINESS WIRE)–Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to … [Read more…]
Suki strengthens its leadership team in US and India and appoints Belwadi Srikanth as the new Vice President, Product and Design; along with Anmol Rastogi as Senior Director, Product Management REDWOOD CITY, Calif.–(BUSINESS WIRE)–Suki, the leader in voice artificial intelligence (AI) technology for healthcare, announced today that it has grown its product team with the … [Read more…]
CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX) today announced the closing of its previously announced registered direct offering with a single healthcare-focused U.S. institutional investor for the purchase of 48,000,000 shares of the Company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 48,000,000 shares of common stock at a combined … [Read more…]
Reflects QuidelOrtho’s confidence in its strong balance sheet and cash generation QuidelOrtho continues to prioritize investments in R&D, manufacturing capacity, and debt paydown SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it has filed an amended complaint against Foresight Diagnostics. The amended complaint asserts a newly-issued patent in Personalis’ growing intellectual property portfolio relating to detection of molecular residual disease (MRD). The patent, US Patent No. 11,408,033 (the “‘033 patent”), … [Read more…]
